Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury

[1]  Xiaohui Li,et al.  Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function , 2018, Nature Communications.

[2]  H. Castrop,et al.  Renal Interstitial Platelet-Derived Growth Factor Receptor-β Cells Support Proximal Tubular Regeneration. , 2018, Journal of the American Society of Nephrology : JASN.

[3]  Youhua Liu,et al.  Fibroblast-Specific β-Catenin Signaling Dictates the Outcome of AKI. , 2018, Journal of the American Society of Nephrology : JASN.

[4]  L. Lau,et al.  Resolution of organ fibrosis , 2018, Journal of Clinical Investigation.

[5]  R. Kramann,et al.  Gli1+ Pericyte Loss Induces Capillary Rarefaction and Proximal Tubular Injury. , 2017, Journal of the American Society of Nephrology : JASN.

[6]  K. Yokote,et al.  Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells , 2016, Nature Communications.

[7]  Raymond Vanholder,et al.  International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology , 2015, The Lancet.

[8]  Lei Jiang,et al.  Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis , 2015, Kidney international.

[9]  Weizhen Zhang,et al.  Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway , 2014, Proceedings of the National Academy of Sciences.

[10]  Lei Jiang,et al.  Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury. , 2014, Kidney international.

[11]  M. Boerries,et al.  mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress , 2014, Proceedings of the National Academy of Sciences.

[12]  Dudley Lamming,et al.  Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2) , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  S. Gygi,et al.  Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signaling to suppress tumorigenesis , 2013, Nature Cell Biology.

[14]  L. Platanias,et al.  The evolution of the TOR pathway and its role in cancer , 2013, Oncogene.

[15]  W. Liu,et al.  Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. , 2013, Journal of the American Society of Nephrology : JASN.

[16]  Youhua Liu,et al.  Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury , 2013, Kidney international.

[17]  P. Rabinovitch,et al.  mTOR is a key modulator of ageing and age-related disease , 2013, Nature.

[18]  P. Igarashi,et al.  Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice , 2012, Kidney international.

[19]  J. Bonventre,et al.  Cellular pathophysiology of ischemic acute kidney injury. , 2011, The Journal of clinical investigation.

[20]  J. Bonventre,et al.  Repair of injured proximal tubule does not involve specialized progenitors , 2011, Proceedings of the National Academy of Sciences.

[21]  B. Molitoris,et al.  Pathophysiology of ischemic acute kidney injury , 2011, Nature Reviews Nephrology.

[22]  P. Worley,et al.  Rheb1 is required for mTORC1 and myelination in postnatal brain development. , 2011, Developmental cell.

[23]  B. Kennedy,et al.  The TOR pathway comes of age. , 2009, Biochimica et biophysica acta.

[24]  D. Sabatini,et al.  DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.

[25]  A. Cohen,et al.  Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. , 2009, Stem cells and development.

[26]  M. Le Hir,et al.  The renal cortical interstitium: morphological and functional aspects , 2008, Histochemistry and Cell Biology.

[27]  A. McMahon,et al.  Intrinsic epithelial cells repair the kidney after injury. , 2008, Cell stem cell.

[28]  G. Remuzzi,et al.  Insulin-like growth factor-1 sustains stem cell mediated renal repair. , 2007, Journal of the American Society of Nephrology : JASN.

[29]  N. Lloberas,et al.  HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. , 2006, Kidney international.

[30]  P. Devarajan.  Update on mechanisms of ischemic acute kidney injury. , 2006, Journal of the American Society of Nephrology : JASN.

[31]  Kebin Hu,et al.  Hepatocyte Growth Factor Is a Downstream Effector that Mediates the Antifibrotic Action of Peroxisome Proliferator–Activated Receptor-γ Agonists , 2005 .

[32]  A. Hishida,et al.  Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate-induced acute renal failure in rats , 2005, Virchows Archiv.

[33]  Jie Chen,et al.  regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. , 2004, Diabetes.

[34]  A. Joyner,et al.  Dynamic Changes in the Response of Cells to Positive Hedgehog Signaling during Mouse Limb Patterning , 2004, Cell.

[35]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[36]  Youhua Liu.  Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. , 2004, American journal of physiology. Renal physiology.

[37]  J. Blenis,et al.  Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.

[38]  B. Edgar,et al.  Rheb promotes cell growth as a component of the insulin/TOR signalling network , 2003, Nature Cell Biology.

[39]  J. Bonventre.  Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. , 2003, Journal of the American Society of Nephrology : JASN.

[40]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[41]  Junwei Yang,et al.  Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. , 2002, Journal of the American Society of Nephrology : JASN.

[42]  Youhua Liu.  Hepatocyte growth factor and the kidney , 2002, Current opinion in nephrology and hypertension.

[43]  K. Matsumoto,et al.  Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. , 2001, Kidney international.

[44]  A. Hishida,et al.  Possible involvement of myofibroblasts in cellular recovery of uranyl acetate-induced acute renal failure in rats. , 2000, The American journal of pathology.

[45]  A. Hoeflich,et al.  Hepatocyte growth factor in renal failure: promise and reality. , 2000, Kidney international.

[46]  W. Lieberthal,et al.  Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. , 1996, The American journal of physiology.

[47]  C. Barnes,et al.  rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. , 1994, The Journal of biological chemistry.

[48]  H. Takahashi-Iwanaga.  The three-dimensional cytoarchitecture of the interstitial tissue in the rat kidney , 1991, Cell and Tissue Research.

[49]  J. Bonventre,et al.  Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair. , 2011, Contributions to nephrology.

[50]  Junwei Yang,et al.  Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress. , 2008, International journal of clinical and experimental pathology.

[51]  Kebin Hu,et al.  hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. , 2006, Journal of the American Society of Nephrology : JASN.